Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. (OLMA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
olma · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$48.00
Consensus
$41.88
+315.5% upside
Low
$35.00
Median: $41.5 · Last Close: $10.08
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$41.88
315.5% upside
High Target
$48
376.2%
Low Target
$35
247.2%
Current Price
$10.08
as of today
Based on analyst price targets, the OLMA stock price prediction for the next 12 months ranges from $35 to $48. The consensus OLMA price forecast of $41.88 implies 315.5% upside from the current price of $10.08.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $9.58 | ↓ 5.00% |
1-day model range: $9.48–$9.67. Peak: $9.67 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OLMA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-18 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-18 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-17 | Citigroup | Maintains | Buy→Buy |
| 2026-03-17 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-12 | Citigroup | Maintains | Buy→Buy |
| 2025-12-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-11 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-12-11 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Olema Pharmaceuticals, Inc. (OLMA) stock. Of the recent 52 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover OLMA.
Analyst Recommendation Trends
OLMA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 98.3% YoY
Revenue Next Year
$33M
↑ 1356.6% YoY
EPS This Year
$-2.20
EPS Next Year
$-2.32
↑ 5.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast OLMA EPS of $-2.20 for the current fiscal year, based on estimates from 8 analysts. The OLMA revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OLMA stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OLMA price target is $41.88 (+315.5% upside), with an analyst consensus of Buy.
The OLMA short-term stock prediction for tomorrow is $9.58 (-5.00%).
Olema Pharmaceuticals, Inc. trades on NASDAQ under the ticker OLMA. The OLMA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
OLMA forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month OLMA price target is $41.88, with a high forecast of $48.00 and a low of $35.00. The median price target is shown in the chart above when available. This implies +315.5% potential upside from the current price of $10.08.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.